Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study

  title={Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study},
  author={Davide Balmativola and Caterina Marchi{\`o} and Milena Maria Maule and Luigi Chiusa and Laura Annaratone and Francesca Maletta and Filippo Montemurro and Janina Kulka and Pedro N. Figueiredo and Zsuzsanna Varga and Inta Liepniece-Karele and G{\'a}bor Cserni and Evdokia Arkoumani and Isabel Amendoeira and Grace M Callagy and Angelika Reiner-Concin and Alicia R C{\'o}rdoba and Simone Bianchi and Tim Decker and Doreen Gl{\"a}ser and Cornelia M. Focke and Paul J van Diest and Dorthe Aamand Grabau and Esther H. Lips and Jelle Wesseling and Riccardo Arisio and Enzo Medico and Cecilia Wells and Anna Sapino},
  booktitle={Breast Cancer Research and Treatment},
To identify markers of non-response to neoadjuvant chemotherapy (NAC) that could be used in the adjuvant setting. Sixteen pathologists of the European Working Group for Breast Screening Pathology reviewed the core biopsies of breast cancers treated with NAC and recorded the clinico-pathological findings (histological type and grade; estrogen, progesterone receptors, and HER2 status; Ki67; mitotic count; tumor-infiltrating lymphocytes; necrosis) and data regarding the pathological response in… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 11 extracted citations


Publications referenced by this paper.
Showing 1-10 of 47 references

Association of increased tumor-infiltrating lymphocytes (TILs) with immunomodulatory (IM) triple-negative breast cancer (TNBC) subtype and response to neoadjuvant platinum-based therapy in PrECOG0105

  • S Vinayak, RJ Gray, +7 authors ML Telli
  • J Clin Oncol 32:S1000
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…